Risks of extended-spectrum beta-lactamases
Extended-spectrum beta-lactamases (ESBLs) are an increasingly important cause of multi-drug resistant infections throughout the world.1,2 Bacteria carrying such enzymes have long been recognised as a cause of healthcare-associated infection.3 However, of concern, the incidence of such organisms also appears to be increasing in the community, typically as a cause of urinary tract infection.1,4 Infections due to ESBL-producing organisms can pose a major threat to life; are often difficult and expensive to treat; and can delay discharge from hospital.5–8 Here we discuss the bacteria that produce ESBLs and treatment of patients who are infected with such organisms.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
(2008). What role for {blacktriangledown}tigecycline in infections?. DTB
46: 62-64
[Abstract] [Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
